Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart Cart lightblue
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Location


Corporate Headquarters

Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States

Telephone Numbers



Customer Service: (800) 227-6666 / (650) 697-3600


Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C54540-100 100 µg (0.5 mg/ml) $503 
ACTR1A / Centractin Antibody - Antibody staining (2 ug/ml) of human kidney lysate (RIPA buffer, 35 ug total protein per lane). Primary incubated for 1 hour. Detected by Western blot of chemiluminescence.
ACTR1A / Centractin Antibody - Antibody staining (1 ug/ml) of human brain lysate (RIPA buffer, 35 ug total protein per lane). Primary incubated for 1 hour. Detected by Western blot of chemiluminescence.
ACTR1A / Centractin Antibody - Antibody staining (2 ug/ml) of human kidney lysate (RIPA buffer, 35 ug total protein per lane). Primary incubated for 1 hour. Detected by Western blot of chemiluminescence.
ACTR1A / Centractin Antibody - Antibody staining (1 ug/ml) of human brain lysate (RIPA buffer, 35 ug total protein per lane). Primary incubated for 1 hour. Detected by Western blot of chemiluminescence.
1 of 2
2 of 2

Polyclonal Goat anti‑Human ACTR1A / Centractin Antibody (aa363‑375, WB) LS‑C54540

Polyclonal Goat anti‑Human ACTR1A / Centractin Antibody (aa363‑375, WB) LS‑C54540

Note: This antibody replaces LS-C63642
Antibody:
ACTR1A / Centractin Goat anti-Human Polyclonal (aa363-375) Antibody
Application:
WB, Peptide-ELISA
Reactivity:
Human, Monkey, Mouse, Rat, Bat, Bovine, Dog, Hamster, Horse, Pig, Rabbit
Format:
Unconjugated, Unmodified
Price
Catalog Number
$503
LS-C54540-100
Toll Free North America
(800) 227-6666
For Research Use Only

Overview

Antibody:
ACTR1A / Centractin Goat anti-Human Polyclonal (aa363-375) Antibody
Application:
WB, Peptide-ELISA
Reactivity:
Human, Monkey, Mouse, Rat, Bat, Bovine, Dog, Hamster, Horse, Pig, Rabbit
Format:
Unconjugated, Unmodified

Specifications

Description
Centractin antibody LS-C54540 is an unconjugated goat polyclonal antibody to Centractin (ACTR1A) (aa363-375) from human. It is reactive with human, mouse, rat and other species. Validated for Peptide-ELISA and WB.
Target
Human ACTR1A / Centractin
Synonyms
ACTR1A | ARP1 | CTRN1 | Actin-RPV | Alpha-centractin | Centractin
Host
Goat
Reactivity
Human, Monkey, Mouse, Rat, Bat, Bovine, Dog, Hamster, Horse, Pig, Rabbit (tested or 100% immunogen sequence identity)
Clonality
Polyclonal
Conjugations
Unconjugated
Purification
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Modifications
Unmodified
Immunogen
Peptide with sequence C-YEEDGARSIHRKT, from the C-Terminus of protein sequence according to NP_005727.1.
Epitope
aa363-375
Specificity
Human ACTR1A. This epitope was selected to minimise the chance of cross-reactivity with ACTR1B (YEEDGSRAIHRKT).
Applications
  • Western blot (1 - 3 µg/ml)
  • Peptide Enzyme-Linked Immunosorbent Assay (1:1000)
Presentation
TBS, pH 7.3, 0.02% Sodium Azide, 0.5% BSA
Storage
Aliquot and store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About ACTR1A / Centractin
P61163 NM_005736 NP_005727.1

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 11/22/2024